Department of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
J Surg Res. 2021 Jul;263:215-223. doi: 10.1016/j.jss.2021.01.040. Epub 2021 Mar 7.
Extracellular matrix (ECM) bioscaffolds produced by decellularization of source tissue have been effectively used for numerous clinical applications. However, decellularized tracheal constructs have been unsuccessful due to the immediate requirement of a functional airway epithelium on surgical implantation. ECM can be solubilized to form hydrogels that have been shown to support growth of many different cell types. The purpose of the present study is to compare the ability of airway epithelial cells to attach, form a confluent monolayer, and differentiate on homologous (trachea) and heterologous (urinary bladder) ECM substrates for potential application in full tracheal replacement.
Porcine tracheas and urinary bladders were decellularized. Human bronchial epithelial cells (HBECs) were cultured under differentiation conditions on acellular tracheal ECM and urinary bladder matrix (UBM) bioscaffolds and hydrogels and were assessed by histology and immunolabeling for markers of ciliation, goblet cell formation, and basement membrane deposition.
Both trachea and urinary bladder tissues were successfully decellularized. HBEC formed a confluent layer on both trachea and UBM scaffolds and on hydrogels created from these bioscaffolds. Cells grown on tracheal and UBM hydrogels, but not on bioscaffolds, showed positive-acetylated tubulin staining and the presence of mucus-producing goblet cells. Collagen IV immunolabeling showed basement membrane deposition by these cells on the surface of the hydrogels.
ECM hydrogels supported growth and differentiation of HBEC better than decellularized ECM bioscaffolds and show potential utility as substrates for promotion of a mature respiratory epithelium for regenerative medicine applications in the trachea.
通过对来源组织进行脱细胞处理而生成的细胞外基质 (ECM) 生物支架已被有效地用于许多临床应用。然而,由于在外科植入时对功能性气道上皮的即时需求,脱细胞气管构建体尚未成功。ECM 可以溶解以形成水凝胶,已证明这些水凝胶可以支持许多不同细胞类型的生长。本研究的目的是比较气道上皮细胞在同源 (气管) 和异源 (膀胱) ECM 基质上附着、形成连续单层和分化的能力,以期在全气管替代中应用。
猪气管和膀胱进行脱细胞处理。在分化条件下,人支气管上皮细胞 (HBEC) 在脱细胞气管 ECM 和膀胱基质 (UBM) 生物支架和水凝胶上培养,并通过组织学和免疫标记评估纤毛形成、杯状细胞形成和基膜沉积的标志物。
气管和膀胱组织均成功脱细胞。HBEC 在气管和 UBM 支架以及由这些生物支架制成的水凝胶上形成了连续的层。在气管和 UBM 水凝胶上生长的细胞,但不在生物支架上生长的细胞,显示出乙酰化微管蛋白阳性染色和产生粘液的杯状细胞的存在。胶原 IV 免疫标记显示这些细胞在水凝胶表面沉积了基膜。
ECM 水凝胶比脱细胞 ECM 生物支架更能支持 HBEC 的生长和分化,并且作为促进再生医学应用中成熟呼吸上皮的基质具有潜在的应用价值。